Enanta Pharmaceuticals (ENTA) Treasury Shares (2012 - 2026)
Enanta Pharmaceuticals' (ENTA) quarterly Treasury Shares came in at $2000.0 in Q2 2015, little changed YoY from $2000.0 in Q2 2014, and little changed on a QoQ basis from $2000.0 in Q1 2015.
Enanta Pharmaceuticals (ENTA) Treasury Shares (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 4 years of Treasury Shares data on file, last reported at $2000.0 in Q2 2015.
- Quarterly Treasury Shares changed 0.0% year-over-year to $2000.0 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $2000.0 (changed 0.0% YoY) and the FY2014 annual result came in at $2000.0, changed 0.0% from the prior year.
- Treasury Shares was little changed at $2000.0 in Q2 2015, from $2000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $443000.0 in Q1 2024 to a low of $81000.0 in Q1 2023.
- A 5-year average of $298764.7 and a median of $411000.0 in 2023 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 0.0% in 2013, down 0.0% in 2013.
- Tracing ENTA's Treasury Shares over 4 years: stood at $2000.0 in 2012, then changed by 0.0% to $2000.0 in 2013, then changed by 0.0% to $2000.0 in 2014, then changed by 0.0% to $2000.0 in 2015.
- The last three Treasury Shares figures came in at $2000.0 (Q2 2015), $2000.0 (Q1 2015), and $2000.0 (Q4 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - | 420,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 420,000.00 |
| Jun 30, 2026 | 420,000.00 |
| Mar 31, 2026 | 420,000.00 |
| Mar 31, 2026 | 420,000.00 |
| Dec 31, 2025 | 425,000.00 |
| Dec 31, 2025 | 425,000.00 |
| Sep 30, 2025 | 408,000.00 |
| Sep 30, 2025 | 408,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | 427,000.00 |
| Mar 31, 2025 | 427,000.00 |
| Dec 31, 2024 | 438,000.00 |
| Dec 31, 2024 | 438,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 436,000.00 |
| Jun 30, 2024 | 436,000.00 |
| Mar 31, 2024 | 443,000.00 |
| Mar 31, 2024 | 443,000.00 |